Moreover, these Lgr5+ cancer cells were functional SCs, as selective ablation of these cells by acute or chronic DT treatment in both organoid-derived and primary tumor-derived cells abolished organoid outgrowth (Figures 4C; Figures S4A–S4F). The gene discussed is LGR5; the disease is cancer.